期刊文献+

沙利度胺下调JNK信号通路抑制肺纤维化大鼠Ⅰ型胶原蛋白的过度表达 被引量:1

Thalidomide inhibits the over expression of type I collagen in pulmonary fibrosis rats via inhibiting JNK signaling pathway
原文传递
导出
摘要 目的探讨沙利度胺抑制肺纤维化大鼠I型胶原蛋白的过度表达,从而减轻博莱霉素诱导的大鼠肺间质纤维化的机制。方法将90只健康雄性W[star大鼠随机分为对照组(N组)、模型组(M组)、沙利度胺组(T组)、SP600125组(SP组)和沙利度胺+SP600125组(T+SP组)。气管内滴注博莱霉素(BLM)5mg/kg生理盐水诱导肺纤维模型,于造模当日起,各组给予相应药物,第7、14、28天处死大鼠,取肺组织行苏木素一伊红(HE)染色和Masson染色,光镜下观察肺泡炎和肺纤维化程度;碱水解法检测肺组织羟脯氨酸(Hyp)含量;免疫印迹法(Westernblot法)、实时荧光定量PCR法检测肺组织中c—jun氨基末端激酶(JNK)及I型胶原蛋白表达水平。结果M组第7天肺泡炎性程度最严重,第28天形成显著肺纤维化,Hyp含量于第28天达高峰,其p—JNK、I型胶原蛋白含量与对照组比较均明显升高(F=277.87、472.51,均P〈0.01);T组、SP组和T+SP组各时间点肺泡炎和纤维化程度均低于M组,p-JNK、I型胶原蛋白含量亦低于M组(F=14.77、61.59、101.73,均P〈0.01;F=10.33、79.12、57.48,均P〈0.01);SP组P—JNK含量与T+SP组比较差异无统计学意义。结论沙利度胺可能通过下调JNK信号通路抑制肺纤维化大鼠I型胶原蛋白的过度表达,从而减轻大鼠肺间质纤维化。 Objective To investigate whether thalidomide inhibits the over expression of type I collagen in pulmonary fibrosis rats via inhibiting the JNK signaling pathway, thereby reducing bleomycin-induced pulmonary interstitial fibrosis in rats. Methods 90 healthy male SD rats were randomly divided into normal control group (group N), model group (group M), thalidomide group (group T), SP600125 group (group SP) and thalidomide+SP600125 group (group T+SP). The pulmonary fibrosis models were prepared via intratracheal injection of 5mg/kg bleomycin, and rats in groups were given corresponding drugs from the first day after preparing model. Rats were randomly sacrificed at 7, 14 and 28 days after treatment. The degree of pulmonary alveolitis and fibrosis was evaluated by H^E and trichrome masson stainings. The level of hydroxyproline in the lung tissue was detected by applying alkaline hydrolysis technique, and expression levels of p-JNK and type I collagen were tested by Western bloting for protein expression and real-time polymerase chain reaction (RT- PCR) for mRNA expression. Results In group M, alveolitis was the most serious on day 7; a marked pulmonary fibrosis formed on day 28; the level of hydroxyproline also peaked on day 28, and the contents of p-JNK and type I collagen were higher than in group N(F=277.87,472. ,51, both P~ 0.01). Group T, SP and T+SP showed mild alveolitis and fibrosis at all time points, and their levels of hydroxyproline, p-JNK and type 1 collagen were remarkably decreased as compared with group M (F= 14.77, 61.59,101.73, all P〈0.01;F= 10.33,79.12,57.48, all P〈0.01).No significant difference in p-JNK was found between group SP and group T-uSP. Conclusions Thalidomide may inhibit the over expression of type I collagen in pulmonary fibrosis rats via inhibiting the JNK signaling pathway, thereby reducing bleomyein-induced pulmonary interstitial fibrosis in rats.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2013年第12期1351-1355,共5页 Chinese Journal of Geriatrics
基金 山西省自然科学基金(2012011037-5) 山西省卫生厅攻关项目(2011021)
关键词 肺纤维化 胶原I型 JNK丝裂原活化蛋白激酶类 Pulmonary fibrosis Collagen type J_ J N K mitogen-acnvated protein kmases
  • 相关文献

参考文献15

  • 1Hou N, Tori'i S, Saito N, et al. Reactive oxygen species-mediated pancreatic beta-cell death is regulated by interactions between stress-activated protein kinases, p38 and c-Jun N-terminal kinase, and mitogewactivated protein kinase phosphatases. Endocrinology, 2008, 149.. 1654-1665.
  • 2Smith JL, Schaffner AE, Hofmeister JK, et al. Ets- 2 is a target for an akt (Proteinkinase B)/jun N- terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice. J Mol Cell Biol, 2000, 20.. 8026-8034.
  • 3Choe JY, Jung HJ, Park KY, et al. Anti-fibrotic effect of thalidomide through inhibiting TGF-beta- induced ERK1/2 pathways in bleomycin-induced lung fibrosis in mice. Inflamm Res, 2010, 59.. 177-188.
  • 4Arai H, Furusu A, Nishino T, et al. Thalidomide prevents the progression of peritoneal fibrosis in mice. Acta Histochem Cytochem, 2011, 44: 51-60.
  • 5Liang CJ, Yen YH, Hung LY, et al. Thalidomide inhibits fibronectin production in TGF-l-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway. Biochem Pharmacol, 2013,85 : 1594-1602.
  • 6Horton MR, Santopietro V, Mathew L, et al. Thalidomide for the treatment of cough in idiopathic pulmonaryfibrosis: a randomized trial. Ann Intern Med, 2012, 157:398-406.
  • 7Choe JY, Jung HJ, Park KY, et al. Anti-fibrotic effect of thalidomide through inhibiting TGF-beta- induced ERK1/2 pathways in bleomycin-induced lung fibrosis in mice. Inflamm Res, 2010,59:177-188.
  • 8Tabata C, Tabata R, Kadokawa Y, et al. Thalidomide prevents bleomycininduced pulmonary fibrosis in mice. J Immunol, 2007,179:708-714.
  • 9Kostadinova R, Montagner A, Gouranton EM, et al. GWS01516-activated PPAR/8 promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation. Cell Biosci, 2012, 2:34.
  • 10Yoshida K, Kuwano K, Hagimoto N, et al. MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis. J Patho, 2002, 198:388-396.

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部